Related Experiment Videos

Rheumatic fever and post-streptococcal arthritis

Maria Odete E Hilário1, Maria Teresa S L R A Terreri

  • 1Alameda dos Anapurus, 1370 ap 144, 04087-004 São Paulo, Brazil.

Insights

Rheumatic fever, a significant global health issue, is caused by Streptococcus bacteria. Early diagnosis and treatment with benzathine penicillin are crucial for managing this condition and preventing long-term complications.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cardiology

Background:

  • Rheumatic fever remains a major cause of illness and death, particularly in developing nations.
  • Group A beta-haemolytic Streptococcus infection triggers the disease, involving complex immune responses.
  • Key pathogenic factors include molecular mimicry, CD4 T lymphocytes, interleukins, and adhesion molecules.

Purpose of the Study:

  • To review the pathogenesis, clinical manifestations, and management of rheumatic fever.
  • To highlight the role of immune components in disease development.
  • To emphasize current therapeutic strategies and diagnostic considerations.

Main Methods:

  • Literature review of rheumatic fever pathogenesis and clinical features.
  • Analysis of diagnostic criteria and therapeutic options.
  • Examination of the role of specific immune molecules and cells.

Main Results:

  • Arthritis, carditis, and chorea are primary clinical presentations.
  • Asymptomatic carditis is increasingly recognized but not a diagnostic criterion.
  • Echo-Doppler findings for carditis lack diagnostic inclusion.

Conclusions:

  • Benzathine penicillin is the preferred treatment for streptococcal infections and secondary prophylaxis.
  • Effective management relies on prompt treatment and prophylaxis due to penicillin's efficacy and affordability.
  • Understanding the immune mechanisms is vital for future therapeutic advancements.

Related Concept Videos